ESC 365 - What determines the 6-minute walk distance in patients with transthyretin cardiomyopathy?

HFA Premium Access

What determines the 6-minute walk distance in patients with transthyretin cardiomyopathy?

Session: Myocardial disease - clinical 3

Topic: Clinical

Speaker: Mr V. Cejka (Wurzburg, DE)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Mr Vladimir Cejka

Comprehensive Heart Failure Center (CHFC), Wurzburg (Germany)

1 follower

6 more presentations in this session

The T-Amylo score facilitates the diagnostic approach of transthyrretin cardiac amyloidosis

Speaker: Doctor C. Goena Vives (Donostia, ES)

Parvovirus B19 myocarditis: The utility of viral load assessment in determining the significance of a virus positive biopsy in South Africa

Speaker: Doctor K. Hassan (Mossel Bay, ZA)

Takotsubo Syndrome in patients with history of malignancy: clinical features and follow-up

Speaker: Doctor A. Pinho (Porto, PT)

Cardiac amyloidosis in a tertiary care center in south India - a case series

Speaker: Doctor A. Jain (Surat, IN)

Survival analysis in a population with cardiac amyloidosis

Speaker: Doctor A. Garcia (Lisbon, PT)

Access the full session

Myocardial disease - clinical 3

Speakers: Mr V. Cejka, Doctor C. Goena Vives, Doctor K. Hassan, Doctor A. Pinho, Doctor A. Jain...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources